Allergy Immunology Clinical Trials
The following searchable list includes all the Division of Allergy-Immunology, Department of Medicine clinical trials currently looking for participants. Please feel free to contact us with inquiries about any of our ongoing research.
Back to top
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study Of Benralizumab in Patients with Severe Nasal Polyposis (OSTRO)
AstraZeneca is doing this research to find out if an experimental medication called benralizumab could be effective and safe a…
AstraZeneca is doing this research to find out if an experimental medication called benralizumab could be effective and safe and used to treat severe nasal polyposis. Benralizumab is an antibody made in the laboratory that has been made to block the effect of IL-5 at the eosinophil. Antibodies are proteins naturally produced by your body that find foreign substances such as bacteria, fungi, viruses and other substances that enter your body and make them inactive. Benralizumab may help decrease swelling in the air passages of people with nasal polyps.
In order to qualify for the study you must have a total polyp score of at least 5.